Glanbia raises FY EPS guidance, volumes up across all units year-to-date

By Reuters News

- Glanbia PLC GL9.I:

  • GLANBIA - GROUP LIKE-FOR-LIKE REVENUE +9.9% FOR NINE MONTHS ENDED OCT 3 WITH VOLUME GROWTH ACROSS ALL THREE SEGMENTS

  • GLANBIA - Q3 OPTIMUM NUTRITION LFL REVENUE GROWTH OF 26.9% (+0.8% VOLUME; +26.1% PRICE)

  • GLANBIA - OPTIMUM NUTRITION REVENUE +25.8% YEAR-TO-DATE DRIVEN BY STRONG CATEGORY GROWTH, MARKET SHARE GAINS, NEW DISTRIBUTION, PRICING ACTIONS

  • GLANBIA - FY PERFORMANCE NUTRITION REVENUE GUIDANCE TO 16% TO 17% (PREVIOUSLY 12% TO 14%);

  • GLANBIA - RAISES FY GUIDANCE TO ADJUSTED EPS GROWTH OF 22% TO 24% CONSTANT CURRENCY (PREVIOUSLY 17% TO 20%).

  • GLANBIA - FY DAIRY NUTRITION EBITDA GUIDANCE TO $175-180 MILLION (PREVIOUSLY $170-180 MILLION); ALL OTHERS UNCHANGED

  • GLANBIA - PERFORMANCE NUTRITION REVENUE +18.0% YEAR-TO-DATE, HEALTH & NUTRITION REVENUE + 9.8%, DAIRY NUTRITION REVENUE +2.1%

  • GLANBIA - WENDY CHANG SMITH APPOINTED CFO DESIGNATE, EFFECTIVE AS CFO AND EXECUTIVE DIRECTOR FROM 31 MARCH 2027

  • GLANBIA - HEALTH & NUTRITION PRICING DECREASE WAS PREDOMINANTLY DRIVEN BY SOME TARIFF REFUNDS AND VOLUME REBATES TO CUSTOMERS

Further company coverage: GL9.I

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk